To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome

NCT06038916 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Respiratory Distress Syndrome

Interventions

DRUG: STSA-1002 Injection Placebo
DRUG: STSA-1002 Injection

Sponsor

Staidson (Beijing) Biopharmaceuticals Co., Ltd